Literature DB >> 35361647

Association between patent foramen ovale and migraine without aura: a community-based cross-sectional study in China.

Yusha Tang1, Anjiao Peng1, Bo Peng2, Shixu He1, Xia Zhao3, Yuanfeng Zhu3, Wanlin Lai1, Tingting Song1, Lei Chen4.   

Abstract

OBJECTIVES: To assess the influence of patent foramen ovale (PFO) on the prevalence of migraine without aura based on propensity score-matched samples in Southwest China.
DESIGN: Propensity-matched cross-sectional study. PARTICIPANTS: Residents over 20 years of age were recruited from 15 communities of Western China from July 2020 to October 2020. A total of 3741 residents having accepted to undergo contrast-transthoracic echocardiography and a standard structured questionnaire was assessed for the relationship between PFO and migraine without aura. PRIMARY AND SECONDARY OUTCOME MEASURES: The primary outcome measures were the prevalence of migraine without aura across different degrees of right-left shunts.
RESULTS: A total of 3741 participants were included. Among them, 881 participants were diagnosed with PFO. The prevalence of migraine without aura in the PFO group was 12.83%, significantly higher than the other group (7.83%, p<0.0001). Analyses of the matched samples showed that the presence of a PFO increased the morbidity risk of migraine without aura (p < 0.001; OR=1.71, 95% CI 1.19 to 2.47).
CONCLUSION: This community-based cross-sectional study pointed to a strong association between PFO and migraine without aura, especially when the shunt is large. TRIAL REGISTRATION NUMBER: ChiCTR1900024623. © Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.

Entities:  

Keywords:  cardiology; epidemiology; migraine

Mesh:

Year:  2022        PMID: 35361647      PMCID: PMC8971771          DOI: 10.1136/bmjopen-2021-056937

Source DB:  PubMed          Journal:  BMJ Open        ISSN: 2044-6055            Impact factor:   2.692


  31 in total

1.  Guidelines for the Echocardiographic Assessment of Atrial Septal Defect and Patent Foramen Ovale: From the American Society of Echocardiography and Society for Cardiac Angiography and Interventions.

Authors:  Frank E Silvestry; Meryl S Cohen; Laurie B Armsby; Nitin J Burkule; Craig E Fleishman; Ziyad M Hijazi; Roberto M Lang; Jonathan J Rome; Yan Wang
Journal:  J Am Soc Echocardiogr       Date:  2015-08       Impact factor: 5.251

2.  European position paper on the management of patients with patent foramen ovale. Part II - Decompression sickness, migraine, arterial deoxygenation syndromes and select high-risk clinical conditions.

Authors:  Christian Pristipino; Peter Germonpré; Danilo Toni; Horst Sievert; Bernhard Meier; Fabrizio D'Ascenzo; Sergio Berti; Eustaquio Maria Onorato; Francesco Bedogni; Jean-Louis Mas; Paolo Scacciatella; David Hildick-Smith; Fiorenzo Gaita; Paul A Kyrle; John Thomson; Genevieve Derumeaux; Dirk Sibbing; Massimo Chessa; Marius Hornung; Jose Zamorano; Dariusz Dudek; Fabrizio D'Ascenzo; Pierluigi Omedè; Flavia Ballocca; Umberto Barbero; Francesca Giordana; Sebastiano Gili; Mario Iannaccone; Teiji Akagi; Gianpaolo Anzola; John Carroll; Bharat Dalvi; Claudio De Angelis; Ge Junbo; Scott E Kasner; Ina Michel-Behnke; Giuseppe Musumeci; Lars Søndergaard; Giuseppe Tarantini; Giuseppe G L Biondi-Zoccai; Davide Capodanno; Marco Valgimigli; Robert Byrne; Vijay Kunadian
Journal:  Eur Heart J       Date:  2021-01-28       Impact factor: 29.983

3.  Long-term treatment patterns of prophylactic and acute migraine medications and incidence of opioid-related adverse events in patients with migraine.

Authors:  Machaon Bonafede; Kathleen Wilson; Fei Xue
Journal:  Cephalalgia       Date:  2019-02-28       Impact factor: 6.292

Review 4.  The Pittsburgh sleep quality index as a screening tool for sleep dysfunction in clinical and non-clinical samples: A systematic review and meta-analysis.

Authors:  Tatyana Mollayeva; Pravheen Thurairajah; Kirsteen Burton; Shirin Mollayeva; Colin M Shapiro; Angela Colantonio
Journal:  Sleep Med Rev       Date:  2015-02-17       Impact factor: 11.609

Review 5.  Headache in the world: public health and research priorities.

Authors:  Timothy J Steiner
Journal:  Expert Rev Pharmacoecon Outcomes Res       Date:  2013-02       Impact factor: 2.217

6.  Adherence to oral migraine-preventive medications among patients with chronic migraine.

Authors:  Zsolt Hepp; David W Dodick; Sepideh F Varon; Patrick Gillard; Ryan N Hansen; Emily B Devine
Journal:  Cephalalgia       Date:  2014-08-27       Impact factor: 6.292

7.  Body mass index and headaches: findings from a national sample of US adults.

Authors:  E S Ford; C Li; W S Pearson; G Zhao; T W Strine; A H Mokdad
Journal:  Cephalalgia       Date:  2008-08-22       Impact factor: 6.292

8.  Burden of migraine and unmet needs from the patients' perspective: a survey across 11 specialized headache clinics in Korea.

Authors:  Byung-Kun Kim; Min Kyung Chu; Soo Jin Yu; Grazia Dell'Agnello; Jeong Hee Han; Soo-Jin Cho
Journal:  J Headache Pain       Date:  2021-05-24       Impact factor: 7.277

9.  Prevalence of migraine in Han Chinese of Fujian province: An epidemiological study.

Authors:  Qi-Fang Lin; Qiao-Qing Xia; Yu-Li Zeng; Xiao-Yang Wu; Lin-Feng Ye; Long-Teng Yao; Yong-Tong Xin; Gen-Bin Huang
Journal:  Medicine (Baltimore)       Date:  2018-12       Impact factor: 1.817

10.  Characterizing opioid use in a US population with migraine: Results from the CaMEO study.

Authors:  Richard B Lipton; Dawn C Buse; Benjamin W Friedman; Lisa Feder; Aubrey Manack Adams; Kristina M Fanning; Michael L Reed; Todd J Schwedt
Journal:  Neurology       Date:  2020-06-11       Impact factor: 9.910

View more
  1 in total

Review 1.  The Patent Foramen Ovale and Migraine: Associated Mechanisms and Perspectives from MRI Evidence.

Authors:  Wenfei Cao; Yinbo Shen; Jiaqi Zhong; Zhenhong Chen; Nizhuan Wang; Jiajun Yang
Journal:  Brain Sci       Date:  2022-07-18
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.